167 related articles for article (PubMed ID: 35786533)
1. Prediction of survival in patients with colorectal liver metastases- development and validation of a prognostic score model.
Villard C; Abdelrafee A; Habib M; Ndegwa N; Jorns C; Sparrelid E; Allard MA; Adam R
Eur J Surg Oncol; 2022 Dec; 48(12):2432-2439. PubMed ID: 35786533
[TBL] [Abstract][Full Text] [Related]
2. A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver Metastases.
Balachandran VP; Arora A; Gönen M; Ito H; Turcotte S; Shia J; Viale A; Snoeren N; van Hooff SR; Rinkes IH; Adam R; Kingham TP; Allen PJ; DeMatteo RP; Jarnagin WR; D'Angelica MI
Clin Cancer Res; 2016 May; 22(10):2575-82. PubMed ID: 26733613
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
[TBL] [Abstract][Full Text] [Related]
4. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
Bao Q; Wang K; Wang HW; Jin KM; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
[No Abstract] [Full Text] [Related]
5. Primary tumour location affects survival after resection of colorectal liver metastases: A two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score.
Gasser E; Braunwarth E; Riedmann M; Cardini B; Fadinger N; Presl J; Klieser E; Ellmerer P; Dupré A; Imai K; Malik H; Baba H; Ulmer H; Schneeberger S; Öfner D; Dinnewitzer A; Stättner S; Primavesi F
PLoS One; 2019; 14(5):e0217411. PubMed ID: 31150437
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of inter-metastatic heterogeneity of viable tumour cells in colorectal liver metastases.
Strömberg C; Martinez de la Maza L; Fernández Moro C; Gerling M; Jorns C; Sparrelid E; Löhr MJ; Villard C
Eur J Surg Oncol; 2022 Jul; 48(7):1656-1663. PubMed ID: 35307250
[TBL] [Abstract][Full Text] [Related]
7. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
[TBL] [Abstract][Full Text] [Related]
8. Predicting 10-year survival after resection of colorectal liver metastases; an international study including biomarkers and perioperative treatment.
Buisman FE; Giardiello D; Kemeny NE; Steyerberg EW; Höppener DJ; Galjart B; Nierop PMH; Balachandran VP; Cercek A; Drebin JA; Gönen M; Jarnagin WR; Kingham TP; Vermeulen PB; Wei AC; Grünhagen DJ; Verhoef C; D'Angelica MI; Koerkamp BG
Eur J Cancer; 2022 Jun; 168():25-33. PubMed ID: 35430383
[TBL] [Abstract][Full Text] [Related]
9. The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal Liver Metastases.
Shimura Y; Komatsu S; Nagatani Y; Funakoshi Y; Sofue K; Kido M; Kuramitsu K; Gon H; Fukushima K; Urade T; So S; Yanagimoto H; Toyama H; Minami H; Fukumoto T
Ann Surg Oncol; 2023 Oct; 30(11):6603-6610. PubMed ID: 37386304
[TBL] [Abstract][Full Text] [Related]
10. Survival Benefit of and Indications for Adjuvant Chemotherapy for Resected Colorectal Liver Metastases-a Japanese Nationwide Survey.
Kobayashi S; Beppu T; Honda G; Yamamoto M; Takahashi K; Endo I; Hasegawa K; Kotake K; Itabashi M; Hashiguchi Y; Kotera Y; Sakamoto K; Yamaguchi T; Morita S; Tabuchi K; Miyazaki M; Sugihara K
J Gastrointest Surg; 2020 Jun; 24(6):1244-1260. PubMed ID: 31197683
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
Beppu T; Miyamoto Y; Sakamoto Y; Imai K; Nitta H; Hayashi H; Chikamoto A; Watanabe M; Ishiko T; Baba H
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S405-13. PubMed ID: 24570379
[TBL] [Abstract][Full Text] [Related]
12. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
[TBL] [Abstract][Full Text] [Related]
14. A Prognostic Scoring System to Predict Survival Outcome of Resectable Colorectal Liver Metastases in this Modern Era.
Liu W; Zhang W; Xu Y; Li YH; Xing BC
Ann Surg Oncol; 2021 Nov; 28(12):7709-7718. PubMed ID: 34023948
[TBL] [Abstract][Full Text] [Related]
15. Prediction of hepatic lymph node metastases based on magnetic resonance imaging before and after preoperative chemotherapy in patients with colorectal liver metastases underwent surgical resection.
Zhu HB; Xu D; Sun XF; Li XT; Zhang XY; Wang K; Xing BC; Sun YS
Cancer Imaging; 2023 Feb; 23(1):18. PubMed ID: 36810192
[TBL] [Abstract][Full Text] [Related]
16. Association of genomic profiles and survival in early onset and screening-age colorectal cancer patients with liver metastases resected over 15 years.
Narayan RR; Aveson VG; Chou JF; Walch HS; Sanchez-Vega F; Santos Fernandes GD; Balachandran VP; D'Angelica MI; Drebin JA; Jarnagin WR; Wei AC; Cercek A; Gönen M; Schultz N; Kingham TP
J Surg Oncol; 2022 Apr; 125(5):880-888. PubMed ID: 35066881
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection.
Liu YW; Lu CC; Chang CD; Lee KC; Chen HH; Yeh WS; Hu WH; Tsai KL; Yeh CH; Wee SY; Yin SM; Wang CC; Hung CH
Sci Rep; 2020 Apr; 10(1):6459. PubMed ID: 32296122
[TBL] [Abstract][Full Text] [Related]
18. Nomogram for prediction of prognosis in patients with initially unresectable colorectal liver metastases.
Imai K; Allard MA; Castro Benitez C; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Bismuth H; Baba H; Adam R
Br J Surg; 2016 Apr; 103(5):590-9. PubMed ID: 26780341
[TBL] [Abstract][Full Text] [Related]
19. Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases.
Galjart B; Nierop PMH; van der Stok EP; van den Braak RRJC; Höppener DJ; Daelemans S; Dirix LY; Verhoef C; Vermeulen PB; Grünhagen DJ
Angiogenesis; 2019 May; 22(2):355-368. PubMed ID: 30637550
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B
BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
